| Two-and 6-minute walk tests assess walking capability equally in neuromuscular diseases LK Andersen, KL Knak, N Witting, J Vissing Neurology 86 (5), 442-445, 2016 | 60 | 2016 |
| Reliability of the 2-and 6-minute walk tests in neuromuscular diseases KL Knak, LK Andersen, N Witting, J Vissing Journal of Rehabilitation Medicine 49 (4), 362-366, 2017 | 33 | 2017 |
| Muscle contractility in spinobulbar muscular atrophy JR Dahlqvist, ST Oestergaard, NS Poulsen, KL Knak, C Thomsen, ... Scientific Reports 9 (1), 4680, 2019 | 22 | 2019 |
| Physical activity in myotonic dystrophy type 1 KL Knak, AM Sheikh, N Witting, J Vissing Journal of Neurology 267, 1679-1686, 2020 | 14 | 2020 |
| Intrarater reliability and validity of outcome measures in myotonic dystrophy type 1 KL Knak, AM Sheikh, H Andersen, N Witting, J Vissing Neurology 94 (24), e2508-e2520, 2020 | 13 | 2020 |
| Muscle strength and aerobic capacity in patients with CIDP one year after participation in an exercise trial LK Markvardsen, AKR Carstens, KL Knak, K Overgaard, J Vissing, ... Journal of neuromuscular diseases 6 (1), 93-97, 2019 | 13 | 2019 |
| Progressive fat replacement of muscle contributes to the disease mechanism of patients with single, large-scale deletions of mitochondrial DNA G Hedermann, JR Dahlqvist, N Løkken, CR Vissing, KL Knak, ... Neuromuscular Disorders 28 (5), 408-413, 2018 | 11 | 2018 |
| Stable Longitudinal Methylation Levels at the CpG Sites Flanking the CTG Repeat of DMPK in Patients with Myotonic Dystrophy Type 1 M Hildonen, KL Knak, M Dunø, J Vissing, Z Tümer Genes 11 (8), 936, 2020 | 9 | 2020 |
| Aerobic anti‐gravity exercise in patients with Charcot–Marie–Tooth disease types 1A and X: A pilot study KL Knak, LK Andersen, J Vissing Brain and Behavior 7 (12), e00794, 2017 | 9 | 2017 |
| Responsiveness of outcome measures in myotonic dystrophy type 1 KL Knak, AM Sheikh, N Witting, J Vissing Annals of Clinical and Translational Neurology 7 (8), 1382-1391, 2020 | 6 | 2020 |
| Does grip strength reflect isokinetic muscle strength in lower limbs in patients with chronic inflammatory demyelinating polyneuropathy? KL Knak, LK Andersen, I Christiansen, LK Markvardsen Muscle & Nerve 58 (3), 449-452, 2018 | 6 | 2018 |
| The 2-and 6-minute walk tests in neuromuscular diseases: Effect of heart rate correction on the learning effect KL Knak, LK Andersen, N Witting, J Vissing International Journal of Physical Medicine & Rehabilitation 5 (4), 2017 | 6 | 2017 |
| EP. 54Assessment of trunk muscle strength in patients with muscular dystrophies using stationary and hand-held dynamometry: a test-retest reliability study K Rudolf, A Sheikh, K Knak, N Witting, J Vissing Neuromuscular Disorders 29, S116-S117, 2019 | 2 | 2019 |
| Test–retest reliability of the 2-and 6-minute walk tests in patients with neuromuscular diseases K Knak, L Andersen, N Witting, J Vissing Neuromuscular Disorders 25, S273, 2015 | 1 | 2015 |
| Outcome Measures and Physical Activity in Myotonic Dystrophy Type 1 KL Knak | | 2021 |
| Is grip strength compared to lower extremity measurements sufficient for capturing changes in muscle strength in chronic inflammatory demyelinating polyneuropathy? K Knak, L Andersen, L Markvardsen Neuromuscular Disorders 27, S227-S228, 2017 | | 2017 |
| Aerobic anti-gravity exercise in patients with Charcot-Marie-Tooth disease. Types: a pilot study K Knak, L Andersen, J Vissing Neuromuscular Disorders 27, S147, 2017 | | 2017 |
| Axial myopathy in patients with neuromuscular diseases K Rudolf, K Knak, N Witting, J Vissing Neuromuscular Disorders 27, S244, 2017 | | 2017 |
| Structural muscle involvement in patients with chronic progressive external ophthalmoplegia assessed by quantitative MRI G Hedermann, N Løkken, J Dahlqvist, C Vissing, K Knak, L Andersen, ... Neuromuscular Disorders 25, S207, 2015 | | 2015 |
| Assessment of the 2-and 6-minute walk test for patients with neuromuscular diseases L Andersen, K Knak, N Witting, J Vissing Neuromuscular Disorders 25, S273, 2015 | | 2015 |
